548 - A Randomized, Double-blind, Controlled Trial of Vancomycin Taper/Pulse and Fidaxomicin compared to Vancomycin for Treatment of a First or Second Recurrence of Clostridioides difficile Infection

Presenting Author(s)

• 

  Stuart Johnson, M.D.

  ID Physician and Researcher
  Hines VA Hospital and Loyola University Medical Center
  Hines, Illinois, United States

  Slides

Co-Author(s)

• DG

  Dale N. Gerding, M.D.

  Edward Hines Jr. VA Hospital
  Hines, Illinois, United States
• 

  Curtis Donskey, MD

  Professor
  Cleveland VA Hospital
  Cleveland, Ohio, United States
• HF

  Hua Feng, Ph.D.

  Edward Hines Jr. VA Hospital
  Hines, Illinois, United States
• NJ

  Neil Johnson, M.S.

  Edward Hines Jr. VA Hospital
  Hines, Illinois, United States
• MJ

  Michelle Johnson, M.P.H.

  Edward Hines Jr. VA Hospital
  Hines, Illinois, United States
• KC

  Kimberly M. Carlson, M.S.

  Edward Hines Jr. VA Hospital
  Hines, Illinois, United States
• LG

  Ling Ge, MS

  Edward Hines VA Hospital
  Hines, Illinois, United States
• AG

  Alexa M. Goldberg, Pharm.D.

  Albuquerque VA Medical Center
  Albuquerque, New Mexico, United States
• DR

  Domenic J. Reda, Ph.D.

  University of Illinois at Chicago
  Chicago, Illinois, United States
• MC

  Michael W. Climo, M.D.

  Richmond VA Medical Center
  Richmond, Virginia, United States
• KG

  Kalpana Gupta, MD, MPH

  Professor of Medicine
  VA Boston Healthcare System and Boston Universiy School of Medicine
  West Roxbury, MA, United States
• 

  Matthew B. Goetz, MD

  Chief, Infectious Diseases
  VA Greater Los Angeles Healthcare System
  Los Angeles, California, United States